A study on CPI-601, a recombinant human palmitoyl-protein thioesterase-1, in cynomolgus monkeys highlights its safety and pharmacokinetics. This research may inform future dosing strategies for conditions related to palmitoyl-protein thioesterase-1 deficiencies.
intracerebroventricular repeat dose cpi 601 recombinant human palmitoyl protein thioesterase 1 in cynomolgus monkey safety pharmacokinetics and dose selection
Original title: “Intracerebroventricular repeat dose CPI-601 recombinant human palmitoyl-protein thioesterase-1 in cynomolgus monkey: safety, pharmacokinetics, and dose selection.”